Science round-up webinar: tDCS in Depression and Chronic Pain – Clinical Advancements 2025
The webinar is scheduled for the 29th of January 2026, at 13:00 CET.
Speaker: Anne Panhelainen, PhD in Neuropharmacology and a Clinical Specialist at Sooma
In this webinar, Anne will walk through the most recent research results from 2025, highlight emerging clinical insights, and discuss what these advancements mean for clinical work.
You will learn, among other things:
- What new clinical evidence tells us about the effectiveness and safety of tDCS in 2025
- How treatment protocols are evolving
- How clinicians can translate the latest findings into everyday practice
This webinar is tailored for healthcare professionals and researchers working with mental health and pain management.
You can sign up by filling out the form below.
Latest news
Sooma closes 2025 with major milestones in improved access to better depression and pain care globally
Read more
FDA approved tDCS for at-home depression treatment
Read more
Sooma launches direct-to-patient brain stimulation therapy for depression and chronic pain in Finland and Germany
Read more